UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008822
Receipt number R000010367
Scientific Title Comparsion of the biocompatibility dialyzer ; AM69 mebrane(Gambro CO.,LTD) VS. polysulfone mebrane (Asahi medical CO.,LTD).
Date of disclosure of the study information 2012/09/02
Last modified on 2016/03/31 15:54:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparsion of the biocompatibility dialyzer ; AM69 mebrane(Gambro CO.,LTD) VS. polysulfone mebrane (Asahi medical CO.,LTD).

Acronym

Comparison of the biocompatibility between AN69 mebrare and polysulfon mebrare.

Scientific Title

Comparsion of the biocompatibility dialyzer ; AM69 mebrane(Gambro CO.,LTD) VS. polysulfone mebrane (Asahi medical CO.,LTD).

Scientific Title:Acronym

Comparison of the biocompatibility between AN69 mebrare and polysulfon mebrare.

Region

Japan


Condition

Condition

Chronic kidney disease

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Comparison of the biocompatibility of a dialyzer

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase I


Assessment

Primary outcomes

White blood count
The number of blood platelets
Beta-thromboglobulin

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Blood data sampling when using PS membrane dialyzer
Data sampling after 2 weeks washout period blood dialyzer change stacked

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

99 years-old >=

Gender

Male and Female

Key inclusion criteria

Maintenance hemodialysis patients.
Patients using the PS membrane dialyzer.
Patients with blood clotting occurs in the dialyzer and blood circuit.
Patients who do not improve after increasing an anti-clotting drug.

Key exclusion criteria

Case of minors subject.
If it is determined objectively and not be able to give informed consent subjects valid for any reason.

Target sample size

6


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yuuji takeda

Organization

Keneikai sankou hospital

Division name

Engineer unit

Zip code


Address

sanko.honbu@earth.ocn.ne.jp

TEL

075-676-0001

Email

sanko.honbu@earth.ocn.ne.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yuuji takeda

Organization

Keneikai sankou hospital

Division name

Engineer unit

Zip code


Address

3-6, Nomi-cho, Takatsuki ctiy, Osaka

TEL

075-676-0001

Homepage URL


Email

sanko.honbu@earth.ocn.ne.jp


Sponsor or person

Institute

Keneikai sankou hospital engineer unit

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

健栄会三康病院(大阪府)、健栄会三康病院附属診療所(大阪府)、健栄会三康クリニック(大阪府)、三康診療所(大阪府)


Other administrative information

Date of disclosure of the study information

2012 Year 09 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2012 Year 06 Month 01 Day

Date of IRB


Anticipated trial start date

2012 Year 06 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 08 Month 31 Day

Last modified on

2016 Year 03 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010367


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name